real-world-evidence
(12)
Bruno Lempernesse
Bruno Lempernesse is the CEO of MDClone, an Israeli-founded healthcare data platform that lets organizations explore and share sensitive patient data using synthetic data that preserves privacy. A 25-year veteran of healthcare technology, data science, and life sciences, he joined MDClone as President of North America in September 2024 and stepped up to Chief Executive Officer in 2025. Before MDClone he was CEO of Carevive, a cancer-care and real-world-studies company acquired by Health Catalyst in 2024, and earlier spent two decades at Cegedim building its data and research business, plus leadership roles at SHYFT Analytics and Acorn AI (a Medidata company). He is an early pioneer of longitudinal patient data drawn from electronic medical records across Europe and the United States.
Derk Arts
Derk Arts is a Dutch physician-turned-entrepreneur and the founder and CEO of Castor, a clinical-trial software company he started in 2012 after coding the first version of its Electronic Data Capture platform himself. Trained as a medical doctor and epidemiologist with a PhD, he built Castor to make clinical research more inclusive, patient-centric, and data-driven. The platform now supports thousands of trials across roughly 90 countries and was used by the World Health Organization for its Solidarity Trial. Castor has raised more than $60 million, including a $45 million Series B in 2021, and Arts is a recognized voice on decentralized trials, eConsent, and the responsible use of AI in research.
Robert Chu
Robert Chu is the co-founder and CEO of Embleema, a New York-based clinical research platform that collects and generates regulatory-grade evidence to accelerate precision medicine. He founded the company in 2017 after nearly three decades in enterprise technology and life sciences data, including roles as Senior Vice President of Global Technology Solutions at IQVIA (formerly QuintilesIMS), where he ran a 1,400-person, $800M SaaS business, and prior leadership positions at IMS Health in France, China, and Asia Pacific, following 15+ years at IBM. Trained as an engineer at Ecole Polytechnique in Paris, he now works at the intersection of patient consent, blockchain, and clinical data collection, with Embleema partnering with pharma sponsors and the FDA on real-world evidence workflows.
Belinda Tan
Belinda Tan is a physician-scientist turned serial founder who builds the missing evidence layer for wellness. An MIT-trained, UCLA MD/PhD dermatopathologist, she co-founded Science 37 to pioneer decentralized, telemedicine-enabled clinical trials, then launched People Science, a Los Angeles public-benefit company she co-leads with her husband Noah Craft. Her mission: bring the rigor of the randomized trial to the things people already use - probiotics, traditional Chinese medicine, food-as-medicine, psychedelics - so wellness can be backed by data instead of marketing.
Vish Srivastava
Vish Srivastava is the co-founder and CEO of Century Health, a New York based AI company turning the messy, unstructured clinical notes buried inside electronic health records into structured, analyzable real-world evidence. Century's abstraction engine, CHARM, reads doctors' notes and pathology reports and pulls out clinical variables with 97% validated accuracy while keeping traceability back to the source document. The company focuses on therapeutic areas like gastroenterology, neurology, and rheumatology, and raised an oversubscribed $5M seed round in May 2026 led by Origin Ventures. Srivastava's pitch is simple and stubborn: the data needed to accelerate medical breakthroughs has already been collected during patient care; it just needs to be made accessible and actionable.
Andrew Kress
Andrew Kress is the co-founder and CEO of HealthVerity, the Philadelphia company that built one of the largest real-world healthcare data ecosystems and the technology to link, govern and exchange it without exposing patient identities. An English major from Yale who spent his career inside the plumbing of healthcare data - running SDI Health, then leading Healthcare Value Solutions at IMS Health - he started HealthVerity in 2014 to make fragmented, privacy-bound health data usable. The company raised $100M in Series D funding in 2021 led by Durable Capital Partners. Kress also serves on the boards of Philadelphia cultural institutions including the Pennsylvania Academy of the Fine Arts.
Jeff Elton
Jeff Elton, Ph.D., is the founding CEO and now Vice Chairman of ConcertAI, a Cambridge-based company building generative and predictive AI on the world's largest multi-modal oncology dataset. He grew the company from a 2017 startup into a roughly $1.9 billion business with about 1,300 employees, acquiring TeraRecon's imaging technology and ASCO's CancerLinQ network along the way. A former Accenture managing director, Novartis research COO, and McKinsey partner, he co-authored the widely cited book Healthcare Disrupted and chairs the MassBio board.
Joel Morse
Joel Morse is the co-founder and CEO of Curavit Clinical Research, a virtual contract research organization (VCRO) that designs and runs decentralized clinical trials for digital therapeutics, devices and drugs. A mechanical engineer turned serial healthcare operator, he previously co-founded C3i Solutions in 1993 and built it into a global leader in tech-enabled clinical trial services before selling to Telerx in 2014. At Curavit he is betting that trials can be run where patients actually live, stitching together wearables, web recruitment and real-world evidence to reach people traditional sites never see.
Zack Scott
Zack Scott is a General Partner and Co-Head of the Healthcare Investment Team at Norwest Venture Partners, one of Silicon Valley's most active multi-stage venture capital firms. A rare combination of clinically trained physician and seasoned investor, Scott brings an MD from UT Health San Antonio and an MBA from Duke's Fuqua School of Business to a career that spans surgical residency, healthcare venture investing at Burrill & Company, co-founding Revelation Partners (a healthcare-focused secondary investment firm), and now leading healthcare deals at Norwest. His portfolio includes companies like ShiraTronics, SetPoint Medical, Cytovale, and Galvanize Therapeutics, with notable exits including Omada Health's IPO and acquisitions by Stryker, Zoll Medical, Abbott, and Olympus.
Dan Riskin
Dan Riskin is a physician-entrepreneur, trauma surgeon, and healthcare AI executive who founded Verantos in 2015 to generate high-validity real-world evidence from messy clinical data. A serial innovator who began coding at age 5 and sold software at 12, Riskin holds an MD from Boston University and an MBA from MIT, is board-certified in four specialties, and serves as Clinical Professor of Surgery at Stanford. His prior company Health Fidelity was acquired for more than $150 million. Today, Verantos powers regulatory and reimbursement decisions for major pharmaceutical companies by turning fragmented EHR data into research-grade evidence at scale.
Mika Newton
Mika Newton is the CEO of xCures Inc., an Oakland-based AI company transforming how cancer patients and oncologists navigate clinical data. With over two decades in life sciences and health technology, she leads a platform that automatically retrieves, structures, and surfaces medical records to support real-world evidence generation and precision oncology - helping patients find clinical trials and helping researchers capture regulatory-grade data at scale.
Todd Gottula
Todd Gottula is CEO and Co-Founder of Clarify Health, a San Francisco-based healthcare analytics platform that maps over 300 million patient journeys and delivers 18 billion-plus AI-predicted precision insights. A Caltech-trained chemical engineer who spent over a decade as EVP and CTO at Advent Software (acquired by SS&C Technologies for $2.7B), Gottula co-founded Clarify in 2015 to bring the data intelligence of banking and consumer industries into healthcare. The company has raised over $401M in total funding, including a $150M Series D in 2022, and earned the #1 KLAS ranking in Data Analytics Platforms for Payers.